Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Childhood Acute Lymphoblastic Leukemia. Strongest funded area: Basic Science. Largest gap: Gene Therapy / Cell Therapy.
Gene Therapy / Cell TherapyFunded, Few Publications
6 funded grants in Gene Therapy / Cell Therapy but only 2 related publications found for childhood acute lymphoblastic leukemia. This may indicate early-stage research that hasn't yet produced published results.
Translational / Drug DevelopmentFunded, Few Publications
5 funded grants in Translational / Drug Development but only 2 related publications found for childhood acute lymphoblastic leukemia. This may indicate early-stage research that hasn't yet produced published results.
Adjacent Research(15 grants)
These grants mention Childhood Acute Lymphoblastic Leukemia as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(15)
OtherU54Active
Reducing Disparities in Acute Leukemia (REDIAL) Consortium
Gramatges, Maria et al.·BAYLOR COLLEGE OF MEDICINE·HOUSTON, TX
